Evidence map›Paper›PMID 41019076›Full record

ReviewFrontiers in immunology2025

Research progress on the mechanisms of interleukin and chemokine families in driving calcium oxalate nephrolithiasis formation.

Fujie Liang, Fuyou Guo, Runjun Liu, Xiang Wang

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Current issues in molecular biology · 2026
    Article
  2. Review
  3. Clinical features ofFrontiers in cellular and infection microbiology · 2026
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Fujie LiangDepartment of Urology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Fuyou GuoDepartment of Urology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Runjun LiuDepartment of Urology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Xiang WangDepartment of Urology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Calcium Oxalate Nephrolithiasis is a globally prevalent urological disorder, with its pathogenesis involving multiple mechanisms such as inflammatory responses, oxidative stress, crystal-cell interactions, macrophage polarization, and fibrosis. In recent years, the multidimensional regulatory roles of interleukins (ILs) and chemokines in stone formation have garnered increasing attention. Pro-inflammatory interleukins, such as IL-1β, may promote crystal deposition, oxidative stress, and renal tubular epithelial cell injury by activating signaling pathways including NLRP3 inflammasome, NF-κB, and MAPK. In contrast, anti-inflammatory interleukins, by stimulating M2 macrophage polarization and suppressing crystal adhesion and oxidative damage, exhibit nephroprotective effects. Notably, IL-6 demonstrates unique bidirectional regulatory properties. Chemokines play critical roles in recruiting immune cells, amplifying inflammatory responses, modulating crystal-cell interactions, and sustaining the fibrosis-stone vicious cycle. The CXCL12/CXCR4 axis has emerged as a potential hub in regulating crystal autophagy and fibrotic progression. Additionally, miR-124-3p overexpression inhibits pro-inflammatory factor expression and promotes M2 macrophage polarization, while the IL-6/MCP-1 axis may reverse this suppression via a negative feedback network. This review integrates the multidimensional regulatory mechanisms of interleukins and chemokines in Calcium Oxalate Nephrolithiasis and proposes three novel hypotheses: the dynamic regulatory model of IL-6, the MCP-1-mediated fibrosis-stone vicious cycle, and the IL-6/MCP-1/miR-124-3p negative feedback loop.

Indexed as

Calcium OxalateChemokinesInterleukinsNephrolithiasisAnimalsFeedback, PhysiologicalHumansInflammationCalcium OxalateChemokinesInterleukinschemokinesinflammationinterleukinkidney stonerenal fibrosis

Identifiers

PMID41019076
PMCPMC12463896

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.